vTv Therapeutics (VTVT) Depreciation and Depletion (2014 - 2026)

vTv Therapeutics (VTVT) has 13 years of Depreciation and Depletion data on file, last reported at $1000.0 in Q1 2026.

• For the quarter ending Q1 2026, Depreciation and Depletion fell 88.89% year-over-year to $1000.0; the trailing twelve-month figure through Mar 2026 stood at $8000.0 (down 89.47% YoY), and the FY2025 full-year result was $16000.0, down 82.02% from the prior year.
• Depreciation and Depletion slipped to $1000.0 in Q1 2026, from $2000.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $31000.0 in Q4 2022 to a low of $1000.0 in Q1 2026.
• A 5-year average of $17411.8 and a median of $22000.0 in 2022 frame the typical range for Depreciation and Depletion.
• Across the five-year window, Depreciation and Depletion surged 40.91% in 2022 and sank 90.91% in 2025, its largest moves.
• Tracing VTVT's Depreciation and Depletion over 5 years: stood at $31000.0 in 2022, then dropped by 25.81% to $23000.0 in 2023, then slipped by 4.35% to $22000.0 in 2024, then slumped by 90.91% to $2000.0 in 2025, then tumbled by 50.0% to $1000.0 in 2026.
• Business Quant data shows VTVT's Depreciation and Depletion at $1000.0 in Q1 2026, $2000.0 in Q4 2025, and $2000.0 in Q3 2025.